Title: Gargle sample is an effective option in a novel molecular point-of-care test for influenza: a multicenter study Short running head: A novel rapid molecular POC test for Flu Authors:

Affiliations: Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Nagasaki, Japan Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan Division of Pulmonary & Critical Care Medicine, University of Michigan, Michigan, Ann Arbor, Michigan, USA Urabe Otorhinolaryngology Clinic, Nagasaki City, Nagasaki, Japan Iida Naika Syounika Clinic, Nagasaki City, Nagasaki, Japan Ohisama Pediatric Clinic, Nagayo-cho, Nagasaki, Japan Nishida Gastrointestinal Internal Medicine Clinic, Nagasaki City, Nagasaki, Japan Onitsuka Internal Medicine Clinic, Nagasaki City, Nagasaki, Japan Department of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Hospital, All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 26, 2022. ; https://doi.org/10.1101/2022.06.03.22275936 doi: medRxiv preprint

[1]  K. Kuronuma,et al.  Comparative study of rapid antigen testing and two nucleic acid amplification tests for influenza virus detection. , 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[2]  K. Morita,et al.  Performance of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients: A retrospective study in outbreak on a cruise ship , 2021, PloS one.

[3]  W. Melchers,et al.  European multicenter evaluation of Xpert® Xpress SARS‐CoV‐2/Flu/RSV test , 2021, Journal of medical virology.

[4]  K. Yanagihara,et al.  Had COVID-19 spread in the community before the first confirmed case in Nagasaki, Japan? , 2021, Microbes and infection.

[5]  K. Yanagihara,et al.  Evaluation of a novel rapid TRC assay for the detection of influenza using nasopharyngeal swabs and gargle samples , 2021, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  K. Yanagihara,et al.  Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A/B and respiratory syncytial virus in patients with influenza-like illness. , 2021, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[7]  R. Selvarangan,et al.  Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children , 2020, Journal of Clinical Microbiology.

[8]  R. Gunson,et al.  In-house validation of the cobas Liat influenza A/B and RSV assay for use with gargles, sputa and endotracheal secretions. , 2019, The Journal of hospital infection.

[9]  C. Yip,et al.  Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  B. Tiran,et al.  Prospective evaluation of three rapid molecular tests for seasonal influenza in patients presenting at an emergency unit. , 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  A. Maclean,et al.  Verification of Cepheid Xpert Xpress Flu/RSV assay for use with gargle samples, sputa and endotracheal secretions. , 2019, The Journal of hospital infection.

[12]  F. Hassan,et al.  Multicenter evaluation of the Alere™ i influenza A&B assay using respiratory specimens collected in viral transport media. , 2018, Diagnostic microbiology and infectious disease.

[13]  L. May,et al.  Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu+ , 2017, Journal of Clinical Microbiology.

[14]  S. Mace,et al.  Multi-center evaluation of the cobas® Liat® Influenza A/B & RSV assay for rapid point of care diagnosis. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[15]  G. Gore,et al.  Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction , 2017, Annals of Internal Medicine.

[16]  D. Price,et al.  Diagnostic accuracy and cost analysis of the Alere™ i Influenza A&B near-patient test using throat swabs. , 2017, The Journal of hospital infection.

[17]  D. Cohen,et al.  Multicenter clinical evaluation of the novel Alere™ i Influenza A&B isothermal nucleic acid amplification test. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[18]  J. Katada,et al.  Clinical evaluation of highly sensitive silver amplification immunochromatography systems for rapid diagnosis of influenza. , 2013, Journal of virological methods.

[19]  T. West,et al.  Faculty Opinions recommendation of Accuracy of rapid influenza diagnostic tests: a meta-analysis. , 2012 .

[20]  E. Marlowe,et al.  Evaluation of the Cepheid Xpert Flu Assay for Rapid Identification and Differentiation of Influenza A, Influenza A 2009 H1N1, and Influenza B Viruses , 2012, Journal of Clinical Microbiology.

[21]  G. Fadda,et al.  Multicenter Evaluation of a Transcription-Reverse Transcription Concerted Assay for Rapid Detection of Mycobacterium tuberculosis Complex in Clinical Specimens , 2009, Journal of Clinical Microbiology.